Signaling through the epidermal growth factor (EGF) and its family of receptors (i.e., EGFR, HER2/Neu, erbB3, and erbB4) has also been implicated in the growth and progression of prostate cancer [120]. This evidence concerns the gene EGFR and prostate carcinoma.